A self-assembled nanodelivery system enhances the oral bioavailability of daidzein: In vivo characteristics and in vivo performance

Nanomedicine

Volumn 6, Issue 8, 2011, Pages 1365-1379

  Zhang, Zhiwen ^a   Huang, Yan ^a,b   Gao, Fang ^a,c   Gao, Zhiwei ^a   Bu, Huihui ^a   Gu, Wangwen ^a   Li, Yaping ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b JIANGSU UNIVERSITY   (China)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

bioavailability; daidzein; intestinal absorption; mixed micelle; oral delivery

Indexed keywords

DAIDZEIN; PHOSPHATIDYLCHOLINE; SODIUM;

AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; ENDOCYTOSIS; HYDROPHILICITY; IN VITRO STUDY; INTESTINE ABSORPTION; LIPOPHILICITY; MALE; MICELLE; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; STOMACH; SUSPENSION;

ADMINISTRATION, ORAL; ANIMALS; ENDOCYTOSIS; INTESTINAL ABSORPTION; ISOFLAVONES; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 80155125186     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.39     Document Type: Article

References (33)

1. Cooper ER. Nanoparticles: a personal experience for formulating poorly water soluble drugs. J. Control. Release 141, 300-302 (2010).
2. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother. 58, 173-182 (2004).
3. Leitner VM, Guggi D, Krauland AH, Bernkop-Schnrch A. Nasal delivery of human growth hormone: in vitro and in vivo evaluation of a thiomer/glutathione microparticulate delivery system. J. Control. Release 100, 87-95 (2004).
4. Rebecca LC, Miller LA, Ahmed I. The utility of cyclodextrins for enhancing oral bioavailability. J. Control. Release 123, 78-99 (2007).
5. Kennedy M, Hu J, Gao P et al. Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: a case study. Mol. Pharm. 5, 981-993 (2008).
6. Saha P, Kou JH. Effect of solubilizing excipients on permeation of poorly watersoluble compounds across Caco-2 cell monolayers. Eur. J. Pharm. Biopharm. 50, 403-411 (2000).
7. Pouton CW, Porter CJH. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv. Drug Deliv. Rev. 60, 625-637 (2008).
8. Benny O, Fainaru O, Adini A et al. An orally delivered small-molecule formulation with antiangiogenic and anticancer activity. Nat. Biotechnol. 26, 799-807 (2008).
9. Xie S, Pan B, Wang M et al. Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles. Nanomedicine 5, 693-701 (2010).
10. Rabinow BE. Nanosuspensions in drug delivery. Nat. Rev. 3, 785-796 (2004).
11. Chiappetta DA, Hocht C, Taira C, Sosnik A. Efavirena-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability. Nanomedicine 5, 11-23 (2010).
12. Murkies AL, Wilcox G, Davis SR. Clinical review 92: phytoestrogens. J. Clin. Endocrinol. Metab. 83, 297-303 (1998).
13. Foti P, Erba D, Riso P et al. Comparison between daidzein and genistein antioxidant activity in primary and cancer lymphocytes. Arch. Biochem. Biophys. 433, 421-427 (2005).
14. Keung WM, Vallee BL. Kudzu root: an ancient chinese source of modern antidipsotropic agents. Phytochemistry 47, 499-506 (1998).
15. Lo FH, Mak NK, Leung KN. Studies on the anti-tumor activities of the soy isoflavone daidzein on murine neuroblastoma cells. Biomed. Pharmacother. 61, 591-595 (2007).
16. Rimbach G, Boesch-Saadatmandi C, Frank J et al. Dietary isoflavones in the prevention of cardiovascular disease - a molecular perspective. Food Chem. Toxicol. 46, 1308-1319 (2008).
17. Jia TL, Wang HZ, Xie LP et al. Daidzein enhances osteoblast growth that may be mediated by increased bone morphogenetic protein (BMP) production. Biochem. Pharmacol. 65, 709-715 (2003).
18. Qiu F, Chen XY, Song B et al. Influence of dosage forms on pharmacokinetics of daidzein and its main metabolite daidzein-7-Oglucuronide in rats. Acta Pharmacol. Sin. 26, 1145-1152 (2005).n Provides important information of the pharmacokinetic parameters of daidzein with different dosage form.
19. Li Y, Yang D, Chen S, Chan AS. Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods. Pharm. Res. 25, 563-577 (2008).
20. Sikarwar MS, Sharma S, Jain A.K, Parial SD. Preparation, characterization and evaluation of marsupsin - phospholipids complex. AAPS PharmSciTech 9, 129-137 (2008).
21. Hammad MA, Mlle BW. Increasing drug solubility by means of bile salt - phosphatidylcholine-based mixed micelles. Eur. J. Pharm. Biopharm. 46, 361-367 (1998).
22. Hammad MA, Mlle BW. Solubility and stability of tetrazepam in mixed micelles. Eur. J. Pharm. Sci. 7, 49-55 (1998).
23. Jain R, Duvvuri S, Kansara V, Mandava NK, Mitra AK. Intestinal absorption of noveldipeptide prodrugs of saquinavir in rats. Int. J. Pharm. 336, 233-240 (2007).
24. Li M, Si L, Pan H et al. Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion. Int. J. Pharm. 403(1-2), 37-45 (2010).
25. Piskula MK, Yamakoshi J, Iwai Y. Daidzein and genistein but not their glucosides are absorbed from the rat stomach. FEBS Lett. 447, 287-291 (1999).
26. Roger E, Lagarce F, Garcion E, Benoit JP. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis. J. Control. Release 140, 174-181 (2009). n Demonstrates the transport pathway of lipid nanocarriers across the intestinal epithelial cells.
27. von Gersdorff K, Sanders NN, vandenbrouche R et al. The internalization route resulting in successful gene expression depends on both cell line and polyethylenimine polyplex type. Mol. Ther. 14, 745-753 (2006).
28. Matveev S, Li X, Everson W, Smart EJ. The role of caveolae and caveolin in vesicle dependent and vesicle independent trafficking. Adv. Drug Deliv. Rev. 49, 237-250 (2001).
29. Lee SH, Kim YH, Yu HJ et al. Enhanced bioavailability of soy isoflavones by complexation with b-cyclodextrin in rats. Biosci. Biotechnol. Biochem. 71, 2927-2933 (2007).
30. Shen Q, Li X, Yuan D, Jia W. Enhanced oral bioavailability of daidzein by selfmicroemulsifying drug delivery system. Chem. Pharm. Bull. 58, 693-643 (2010).
31. Gao Y, Gu W, Chen L et al. The role of daidzein-loaded sterically stabilized solid lipid nanoparticles in therapy for cardiocerebrovascular diseases. Biomaterials 29, 4129-4136 (2008).
32. Sugawara T, Kushiro M, Zhang H et al. Lysophosphatidylcholine enhances carotenoid uptake from mixed micelles by Caco-2 human intestinal cells. J. Nutr. 131, 2921-2927 (2001).
33. Lakshminarayana R, Raju M, Krishnakantha TP, Baskaran V. Enhanced lutein bioavailability by lyso-phosphatidylcholine in rats. Mol. Cell Biochem. 284, 103-110 (2006).